Morning Overview on MSN
A new genomic test could spare two-thirds of high-risk breast cancer patients from chemotherapy entirely, per ASCO 2026 results
Thousands of women diagnosed with high-risk, estrogen-receptor-positive breast cancer may no longer need chemotherapy, ...
A new DNA test could spare millions of breast cancer patients from chemotherapy. We answer your questions about what it means ...
A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet ...
(RTTNews) - Targeted Genomics LLC, creator of GlutenIDāthe first and only FDA-cleared direct-to-consumer genetic test for celiac diseaseāhas entered a commercial partnership with OraSure Technologies, ...
Did you know that a simple genetic test called DNA testing is all that is needed to understand if you are at risk of ...
Genetic testing can help doctors diagnose some neurological disorders, such as Huntingtonās disease. It can also provide insights into a personās risk of future health conditions. Genetic testing ...
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...
Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...
Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...
It was this oncologist who had a very different recommendation: Try the Oncotype DX Breast Recurrence Score® test, a ...
From IVF clinics to premarital counselling, genetic compatibility testing is becoming part of modern family planning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results